Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jolanta Orzelska‐Górka"'
Autor:
Jolanta Orzelska-Górka, Katarzyna Dos Santos Szewczyk, Monika Gawrońska-Grzywacz, Mariola Herbet, Anna Lesniak, Anna Bielenica, Magdalena Bujalska-Zadrożny, Grażyna Biała
Publikováno v:
Pharmaceuticals, Vol 16, Iss 12, p 1691 (2023)
Two polyphenols–hyperoside (HYP) and protocatechuic acid (PCA) were reported to exert antidepressant activity in rodents after acute treatment. Our previous study also showed that this activity might have been influenced by the monoaminergic system
Externí odkaz:
https://doaj.org/article/960e5d68288c4a39b826795ce0ec52bf
Autor:
Beata Dąbrowska-Bouta, Grzegorz Sulkowski, Jolanta Orzelska-Górka, Lidia Strużyńska, Ewa Kędzierska, Grażyna Biała
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 208, Iss , Pp 111416- (2021)
The increasing production and use of silver nanoparticles (AgNPs) as antimicrobial agents in medicinal and commercial products creates a substantial risk of exposure, especially for infants and children. Our current knowledge concerning the impact of
Externí odkaz:
https://doaj.org/article/008c9807266847959e4cbfb5ff18b470
Autor:
Elżbieta Szacoń, Marzena Rządkowska, Agnieszka A. Kaczor, Ewa Kędzierska, Jolanta Orzelska-Górka, Sylwia Fidecka, Dariusz Matosiuk
Publikováno v:
Molecules, Vol 21, Iss 5, p 582 (2016)
Novel 1-(1,4-alkylaryldisubstituted-4,5-dihydro-1H-imidazo)-3-substituted urea derivatives have been synthesized and evaluated for their central nervous system activity. Compounds 3a–m were prepared in the reaction between the respective 1-alkyl-4-
Externí odkaz:
https://doaj.org/article/fe94e3266f4a4d50b7317becb7137c4c
Autor:
Gabriela Bielecka‐Papierz, Ewa Poleszak, Joanna Listos, Bernadeta Szewczyk, Aleksandra Szopa, Jolanta Orzelska‐Górka, Justyna Turek, Dorota Bederska‐Łojewska, Małgorzata Jakóbczuk, Jarosław Szponar, Sylwia Talarek, Anna Serefko
Publikováno v:
Clinical and Experimental Pharmacology and Physiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3955f90f23ecb8dcea662e1c19a22202
https://doi.org/10.1111/1440-1681.13779
https://doi.org/10.1111/1440-1681.13779
Publikováno v:
International journal of molecular sciences. 23(18)
Schizophrenia and depression are heterogeneous disorders. The complex pathomechanism of the diseases imply that medication responses vary across patients. Many psychotropic drugs are available but achieving optimal therapeutic effect can be challengi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb3729fff37dd7101e99f89130fac9e6
https://pubmed.ncbi.nlm.nih.gov/36142523
https://pubmed.ncbi.nlm.nih.gov/36142523
Autor:
Claudia Sorbi, Livio Casarini, Anna Bielenica, Andrzej J. Bojarski, Rita Bardoni, Paola Fossa, Silvia Limoncella, Pasquale Linciano, Livio Brasili, Anna Lesniak, Grazyna Biala, Magdalena Bujalska-Zadrożny, Grzegorz Satała, Silvia Franchini, Simone Ronsisvalle, Jolanta Orzelska-Górka, Elena Cichero, Ewa Kędzierska, Agata Pawłowska, Antonella Comitato
Publikováno v:
ACS Chemical Neuroscience
Opioids are the gold standard drugs for the treatment of acute and chronic severe pain, although their serious side effects constitute a big limitation. In the search for new and safer drugs, 5-HT1AR agonists are emerging as potential candidates in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9094ae4a04e393ebc77c146a1cfd7b69
http://hdl.handle.net/11567/1037687
http://hdl.handle.net/11567/1037687
Autor:
Grzegorz Sulkowski, Mikołaj Sałek, Jolanta Orzelska-Górka, Joanna Skalska, Lidia Strużyńska, Małgorzata Frontczak-Baniewicz, Beata Dąbrowska-Bouta
Publikováno v:
Toxicology. 408:31-38
The widespread use of silver nanoparticles (AgNPs) in medicine and in multiple commercial products has motivated researchers to investigate their potentially hazardous effects in organisms. Since AgNPs may easily enter the brain through the blood-bra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad555ed21e00765e24245b29a15c262
https://doi.org/10.1016/j.tox.2018.06.009
https://doi.org/10.1016/j.tox.2018.06.009
Publikováno v:
Acta Poloniae Pharmaceutica - Drug Research. 75:989-1001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb68a864c3bcdafaf85628af7aeb56e8
https://doi.org/10.32383/appdr/80855
https://doi.org/10.32383/appdr/80855
Autor:
Jolanta Orzelska-Górka, Ewa Kędzierska, Lila Dabkowska, Ewa Gibula, Tomasz Krzanowski, Monika Wujec
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 31, Iss 2, Pp 69-75 (2018)
How to get a new drug to market? How much time does it take to go from the idea to implementation? In this study we followed the path drugs take from synthesis to introduction to the market. In doing so, articles in the PubMed and the Google Scholar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d07af9cb4032ad6a933dff7f2df9b56
https://doaj.org/article/2ba05d50327346c7b8596d30b2002c33
https://doaj.org/article/2ba05d50327346c7b8596d30b2002c33
Publikováno v:
Neurotoxicity Research
The goal of the present study was to examine the effects of N-methyl-aspartate (NMDA) receptor antagonists-memantine and ketamine and the drugs modifying the NO:cGMP pathway-NG-nitro-L-arginine methyl ester (L-NAME) and 7-nitroindazole (7-NI), the en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fed91393ba475f59ea22b88970f49d2
https://doi.org/10.1007/s12640-017-9810-1
https://doi.org/10.1007/s12640-017-9810-1